ロード中...
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
Myelodysplastic syndrome (MDS) is a heterogeneous group of hematological malignancies with considerably variable prognoses and curable only with hematopoietic cell transplantation (HCT). Few studies comparing MDS HCT outcomes between sibling and umbilical cord blood (UCB) donors exist. Using the Uni...
保存先:
| 出版年: | Bone Marrow Transplant |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5382091/ https://ncbi.nlm.nih.gov/pubmed/27941767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2016.303 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|